The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist
暂无分享,去创建一个
J. Javitch | M. Rives | D. Sames | J A Javitch | A. Kruegel | M M Gassaway | M-L Rives | A C Kruegel | D Sames | M. Gassaway | Madalee Gassaway | Andrew C. Kruegel
[1] Jonathan A. Javitch,et al. Discovery of a Novel Selective Kappa-Opioid Receptor Agonist Using Crystal Structure-Based Virtual Screening , 2013, J. Chem. Inf. Model..
[2] Nanxin Li,et al. Signaling pathways underlying the rapid antidepressant actions of ketamine , 2012, Neuropharmacology.
[3] P. Greengard,et al. Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine , 2007, The European journal of neuroscience.
[4] G. Balboni,et al. Ligands Raise the Constraint That Limits Constitutive Activation in G Protein-coupled Opioid Receptors* , 2013, The Journal of Biological Chemistry.
[5] L. Pozzi,et al. Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism , 1992, Neuropharmacology.
[6] Philip S. Portoghese,et al. Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.
[7] P. Schiller,et al. TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity. , 1993, Journal of medicinal chemistry.
[8] T. Uzbay,et al. Effects of Tianeptine on Onset Time of Pentylenetetrazole-Induced Seizures in Mice: Possible Role of Adenosine A1 Receptors , 2007, Neuropsychopharmacology.
[9] J. Fourtillan,et al. Kinetic profiles of tianeptine and its MC5 metabolite in plasma, blood and brain after single and chronic intraperitoneal administration in the rat , 2010, European Journal of Drug Metabolism and Pharmacokinetics.
[10] D. Lewis,et al. Involvement of cAMP-dependent protein kinase in mu-opioid modulation of NMDA-mediated synaptic currents. , 1997, Journal of neurophysiology.
[11] C. Pae,et al. Tianeptine combination for partial or non‐response to selective serotonin re‐uptake inhibitor monotherapy , 2013, Psychiatry and clinical neurosciences.
[12] Elliott M. Ross,et al. Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the Sphingosine 1-Phosphate/G13 Pathway* , 2007, Journal of Biological Chemistry.
[13] T. Jay,et al. The neurobiological properties of Tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation , 2009, Molecular Psychiatry.
[14] Yan Zhang,et al. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. , 2003, The Journal of pharmacology and experimental therapeutics.
[15] A. Eschalier,et al. Influence of naloxone on antidepressant drug effects in the forced swimming test in mice , 2004, Psychopharmacology.
[16] E. Jutkiewicz,et al. The antidepressant -like effects of delta-opioid receptor agonists. , 2006, Molecular interventions.
[17] James L. Howard,et al. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats , 2005, Psychopharmacology.
[18] E. Fuchs,et al. The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats , 2002, The European journal of neuroscience.
[19] M. Olianas,et al. Direct Agonist Activity of Tricyclic Antidepressants at Distinct Opioid Receptor Subtypes , 2010, Journal of Pharmacology and Experimental Therapeutics.
[20] D. Diamond,et al. Differential effectiveness of tianeptine, clonidine and amitriptyline in blocking traumatic memory expression, anxiety and hypertension in an animal model of PTSD , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[21] P. Gele,et al. The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers. , 1990, Drug metabolism and disposition: the biological fate of chemicals.
[22] A. Eschalier,et al. Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats , 2005, Psychopharmacology.
[23] J. Javitch,et al. 6′-Guanidinonaltrindole (6′-GNTI) Is a G Protein-biased κ-Opioid Receptor Agonist That Inhibits Arrestin Recruitment* , 2012, The Journal of Biological Chemistry.
[24] I. Lucki,et al. Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in Wistar Kyoto Rats , 2010, Neuropsychopharmacology.
[25] H. Manji,et al. Rapid antidepressant effects: moving right along , 2013, Molecular Psychiatry.
[26] C. Lupica,et al. Opioid Receptor Subtype Expression Defines Morphologically Distinct Classes of Hippocampal Interneurons , 1999, The Journal of Neuroscience.
[27] E. Rabiner,et al. Opioids and anxiety , 2011, Journal of psychopharmacology.